WaterBridge Ventures

WaterBridge Ventures is a New Delhi-based early-stage fund partnering with disruptive Indian technology companies, with healthcare and AI/ML in healthcare flagged as live sub-verticals. Check sizes of $1M to $5M place the firm in the meat of Indian seed and small Series A activity, large enough to lead small priced rounds and substantial enough to be a meaningful name on the cap table. The firm’s marketing positioning is generalist tech with thematic AI exposure, which is consistent with the broader pattern among India’s better seed firms.

The healthcare thesis is read off general signaling rather than a dedicated vertical fund: digital health and AI/ML in healthcare are explicitly listed as areas of interest, but founders should expect generalist diligence rather than specialist domain expertise on the partner side. The right founder is building a clear B2B or B2B2C software product with defined Indian enterprise buyers (hospitals, diagnostics chains, pharma, payers, governments) or building Indian-built software with cross-border ambitions. Founders building deep clinical or therapeutic assets that need ten-year capital and FDA-savvy boards will find better fits in dedicated US healthcare funds.

Geographically, the firm’s advantage is access to the Indian founder graph and to follow-on investors in the New Delhi and Bengaluru ecosystems. Cross-border deal-making is feasible but the strongest pull is local. For a founder with Indian operational anchors, WaterBridge can help with talent, customer intros, and follow-on syndication.

The right entry path is a warm intro from a portfolio founder, a fellow Indian VC, or an operator at one of the major Indian accelerators or incubators. The firm reads partner-led decks; cold email is workable but a clear thesis fit is essential. The pitch should lead with the AI moat (data, product, customer outcomes), traction signal, and follow-on plan. Lead with revenue or pipeline data over architectural claims.

Caveats. The healthcare-specific portfolio depth is not as visible publicly as it is for India’s pure-play health funds; do reference calls with at least two existing portfolio founders before deciding the firm is the right lead. The $1M to $5M check range is broad; pin down whether they will lead at your specific size and ownership target before going deep. As with most generalist Indian seed firms, expect founder selection to weigh prior pedigree and traction signal heavily. For an early-stage Indian healthcare AI founder with a credible team and a working product, WaterBridge is a reasonable lead candidate; for sophisticated clinical or therapeutic plays that need specialist boards, look elsewhere.